FAM95B1: A Drug Target / Disease Biomarker (G100133036)

Target Name: FAM95B1

NCBI ID: G100133036

FAM95B1

Other Name(s): Family with sequence similarity 95 member B1 | family with sequence similarity 95 member B1

FAM95B1: A Drug Target / Disease Biomarker

Fam95B1 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the superfamily of proteins known as the FAM (FAM11A) family, which is characterized by the presence of a specific domain called the FAM11A-like domain.

The FAM11A-like domain is a characteristic motif that is found in a variety of proteins that are involved in various cellular processes. This domain is composed of 115 amino acid residues and is characterized by the presence of a specific aromatic amino acid (Asp) at position 121.

FAM95B1 is a protein that is expressed in the brain and is involved in the regulation of various cellular processes, including neurotransmitter signaling, ion channels, and cell signaling pathways. It is also involved in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

One of the key functions of FAM95B1 is its role in the regulation of neurotransmitter signaling. This protein is known to interact with the neurotransmitter acetylcholine, which is involved in the regulation of various cellular processes, including memory and learning. By interacting with acetylcholine, FAM95B1 is able to regulate the levels of acetylcholine in the brain and enhance its effects on neurotransmitter signaling.

In addition to its role in neurotransmitter signaling, FAM95B1 is also involved in the regulation of ion channels and cell signaling pathways. This protein is known to interact with a variety of ion channels, including the sodium (Na+) and calcium (Ca2+) channels. By interacting with these channels, FAM95B1 is able to regulate the flow of electrical current through the cells and influence various cellular processes.

FAM95B1 is also involved in the regulation of cell signaling pathways. This protein is known to interact with a variety of signaling pathways, including TGF-β (transforming growth factor-尾) signaling, NF-kappa-B (nuclear factor-kappa-B) signaling, and PI3K (phosphatidylinositol 3-kinase) signaling. By interacting with these signaling pathways, FAM95B1 is able to regulate the activity of various cellular proteins and influence various cellular processes.

FAM95B1 is also involved in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. This protein is known to interact with the neurotransmitter dopamine, which is involved in the regulation of various cellular processes, including mood, emotion, and motivation. By interacting with dopamine, FAM95B1 is able to regulate the levels of dopamine in the brain and influence the development and progression of various neurological and psychiatric disorders.

In conclusion, FAM95B1 is a protein that is involved in the regulation of various cellular processes, including neurotransmitter signaling, ion channels, and cell signaling pathways. It is also involved in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. Therefore, FAM95B1 is a potential drug target or biomarker for the treatment of these disorders. Further research is needed to fully understand the role of FAM95B1 in these processes and to develop effective treatments for these disorders.

Protein Name: Family With Sequence Similarity 95 Member B1

The "FAM95B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM95B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets